Greta Cagninelli
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Greta Cagninelli has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Anna Fichera
Department of clinical and experimental sciences University of Brescia Brescia Italy
1 shared publication - Federico Prefumo
Obstetrics and Gynecology Unit, IRCCS Istituto Giannina Gaslini Genova Italy
1 shared publication - Giulia Masini
Fetal Medicine Unit Azienda Ospedaliero‐Universitaria Careggi Florence Italy
1 shared publication Lucia Pasquini
Fetal Medicine Unit Azienda Ospedaliero‐Universitaria Careggi Florence Italy
1 shared publicationNicola Fratelli
Division of Obstetrics and Gynecology ASST Spedali Civili Brescia Italy
1 shared publicationTeresa Polimeno
Fetal Medicine Unit Azienda Ospedaliero‐Universitaria Careggi Florence Italy
1 shared publication
Latest Publications
- Open Access
- 18 September 2023
- Published by Wiley in Acta Obstetricia et Gynecologica Scandinavica
- Vol. 102 (12) , 1749-1755
Small‐for‐gestational‐age fetus diagnosed in the second trimester: Possible etiologies and short‐term neonatal outcomes
Introduction: The aim of our study was to investigate the causes of fetal growth P < 0.001). Termination of pregnancy was more common in Group 1 (P < 0.001). No differences in gestational age at delivery, birthweight, intrauterine death or neonatal death were detected within groups. Growth‐restricted fetuses had lower gestational age at delivery, birthweight and number of live births (P < 0.001), higher rates of termination of pregnancy, intrauterine death (P < 0.001) and neonatal death P = 0.002) compared to small‐for‐gestational‐age. In 17 cases a chromosomal abnormality, genetic syndrome or adverse neurological outcome was diagnosed after birth: six from Group 2 (11.3% of live births in this group) and 11 from Group 3 (4.3%).Conclusions: We report that fetal growth <10th percentile diagnosed before 26 weeks is not isolated before birth in 27% of cases. Malformations and chromosomal abnormalities are common etiologies; therefore, detailed anomaly scans and invasive testing should be offered. In addition, there is a residual risk of neonatal death and postnatal diagnosis of a genetic syndrome or neurodevelopmental impairment despite normal prenatal tests. These results expand the small amount of information on the outcome of cases with very early diagnosis of impaired fetal growth currently available and highlight the importance of detailed counseling with couples.
- 18 September 2023
- Published by Wiley in Acta Obstetricia et Gynecologica Scandinavica
- Vol. 102 (12) , 1749-1755
Open AccessSmall‐for‐gestational‐age fetus diagnosed in the second trimester: Possible etiologies and short‐term neonatal outcomes
Introduction: The aim of our study was to investigate the causes of fetal growth P < 0.001). Termination of pregnancy was more common in Group 1 (P < 0.001). No differences in gestational age at delivery, birthweight, intrauterine death or neonatal death were detected within groups. Growth‐restricted fetuses had lower gestational age at delivery, birthweight and number of live births (P < 0.001), higher rates of termination of pregnancy, intrauterine death (P < 0.001) and neonatal death P = 0.002) compared to small‐for‐gestational‐age. In 17 cases a chromosomal abnormality, genetic syndrome or adverse neurological outcome was diagnosed after birth: six from Group 2 (11.3% of live births in this group) and 11 from Group 3 (4.3%).Conclusions: We report that fetal growth <10th percentile diagnosed before 26 weeks is not isolated before birth in 27% of cases. Malformations and chromosomal abnormalities are common etiologies; therefore, detailed anomaly scans and invasive testing should be offered. In addition, there is a residual risk of neonatal death and postnatal diagnosis of a genetic syndrome or neurodevelopmental impairment despite normal prenatal tests. These results expand the small amount of information on the outcome of cases with very early diagnosis of impaired fetal growth currently available and highlight the importance of detailed counseling with couples.